Versican in inflammation and tissue remodeling: the impact on lung disorders - Test2 - elhamkhani - TriplyDB

Versican in inflammation and tissue remodeling: the impact on lung disorders

Versican in inflammation and tissue remodeling: the impact on lung disorders

http://www.wikidata.org/entity/Q28250984

about

Persistence of Innate Immune Pathways in Late Stage Human Bacterial and Fungal Keratitis: Results from a Comparative Transcriptome Analysis Glycosaminoglycans are involved in bacterial adherence to lung cells.Inhibition of versican expression by siRNA facilitates tropoelastin synthesis and elastic fiber formation by human SK-LMS-1 leiomyosarcoma smooth muscle cells in vitro and in vivo.Knockdown of versican V1 induces a severe inflammatory response in LPS-induced acute lung injury via the TLR2-NF-κB signaling pathway in C57BL/6J mice.Versican accumulates in vascular lesions in pulmonary arterial hypertension.Matrix factorization reveals aging-specific co-expression gene modules in the fat and muscle tissues in nonhuman primates.Extracellular matrix hyaluronan signals via its CD44 receptor in the increased responsiveness to mechanical stimulation.Sonic Hedgehog Signaling Regulates Myofibroblast Function during Alveolar Septum Formation in Murine Postnatal Lung.Biological roles of glycans.Provisional matrix: A role for versican and hyaluronan.Interplay of extracellular matrix and leukocytes in lung inflammation.Towards integrating extracellular matrix and immunological pathways.Versican is Produced by Trif- and Type I Interferon-Dependent Signaling in Macrophages and Contributes to Fine-Control of Innate Immunity in Lungs.Versican Deficiency Significantly Reduces Lung Inflammatory Response Induced by Polyinosine-Polycytidylic Acid Stimulation.miR-124 inhibits proliferation, migration and invasion of malignant melanoma cells via targeting versican.Proteoglycans as Immunomodulators of the Innate Immune Response to Lung Infection.Systems approach to the pharmacological actions of HDAC inhibitors reveals EP300 activities and convergent mechanisms of regulation in diabetes.Decreased elastic fibers and increased proteoglycans in the ligamentum flavum of patients with lumbar spinal canal stenosis.Quantifying extracellular matrix turnover in human lung scaffold cultures.A Serological Biomarker of Versican Degradation is Associated with Mortality Following Acute Exacerbations of Idiopathic Interstitial Pneumonia.Regulatory RNA binding proteins contribute to the transcriptome-wide splicing alterations in human cellular senescence.

P2860

Q33701142-4E27E7C8-97A1-473A-BF21-D63B45F2A946 Q36361216-3224A2A0-B0E7-441E-9508-5C80983788DE Q36730629-A33610F5-9A3C-4389-861B-00BB1C9F68E9 Q36931258-43B89026-2D65-4A20-81E1-53622FA873AB Q37248333-2E4BB1B3-D142-48D7-9747-5B8B5C03A1D8 Q37310875-CAAB5937-40BC-4EBC-9201-1E53EDD80807 Q37720528-87E8BF7D-46A8-497A-86B2-9AAF985E2CE4 Q38852931-A066B74F-CBF2-4B05-BF99-CC277B15A76A Q38936714-58852973-DA1C-4DFD-AC5D-01E809966307 Q39033619-7C91E4D0-FC40-4479-81AB-98724343F7F0 Q39080263-706F4EC4-23BA-42F4-8C0C-6156A0232070 Q39191612-AFB5F6E9-14B1-475D-8A97-D6496C6C52C9 Q40045079-6E44205A-7B35-40C9-8E2E-CF33E972D072 Q40432439-FD9EDC8C-190A-48B5-9AC9-B59614D081DA Q42376340-7F77FF8A-C48D-46CF-978C-617D2BE50C79 Q47719302-F44F9129-85C9-4F64-986A-D73FE13C3740 Q48666421-979F94B6-55B2-455B-9A96-5D8E52C6F8E3 Q50206302-4EB65604-D868-4466-ABBB-50C6D528A439 Q52608945-E12558D0-E490-414A-AB53-E4206125E24E Q55262276-B50938B4-C996-4FBF-96F0-240C8763EA99 Q55689517-69A29D86-6722-433C-8FB0-1C73DA094FBD

P2860

Versican in inflammation and tissue remodeling: the impact on lung disorders

http://www.wikidata.org/entity/Q28250984

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Versican in inflammation and tissue remodeling: the impact on lung disorders

@ast

Versican in inflammation and tissue remodeling: the impact on lung disorders

@en

Versican in inflammation and tissue remodeling: the impact on lung disorders

@nl

type

label

Versican in inflammation and tissue remodeling: the impact on lung disorders

@ast

Versican in inflammation and tissue remodeling: the impact on lung disorders

@en

Versican in inflammation and tissue remodeling: the impact on lung disorders

@nl

prefLabel

Versican in inflammation and tissue remodeling: the impact on lung disorders

@ast

Versican in inflammation and tissue remodeling: the impact on lung disorders

@en

Versican in inflammation and tissue remodeling: the impact on lung disorders

@nl

P1433

Q28250984-6C14C48B-DF2C-492F-98BB-626279CF3801

P1476

Q28250984-D76F5F5F-9559-436A-A62C-D47CDC0E50C0

P2093

Q28250984-0559C7BD-BAE5-48B3-A13B-E8AD237DB230

Q28250984-0C707295-ADF4-46D2-BE09-61A6073EFE0C

Q28250984-108E3B5A-9730-429B-BD73-578E7B392545

Q28250984-32B2915F-DF80-4FA4-B0C4-35DDA54A5B95

Q28250984-7461A4B4-59A6-4315-8556-F72C66E7086B

Q28250984-86498E36-DFD6-4F1A-B95D-D20185B87479

Q28250984-AE537DA1-7CEC-4685-94BF-FDBD8C24DE85

Q28250984-B37C61FB-E537-4111-819D-7B75E22376BB

Q28250984-D7D60862-CE3F-46E6-BAE9-F57ACD921C2C

P275

Q28250984-58D0F1ED-C1E8-47B5-A48D-AD8D08FE945A

P2860

Q28250984-0C6E0FCB-604B-4306-8299-E91F2B911700

Q28250984-113D6BDB-952B-4149-87DE-3F3F3DFC8D6A

Q28250984-14BA501C-4309-4217-A3B7-6F7215965BF1

Q28250984-184AA01A-3168-4530-B8C8-51E50D92CDAF

Q28250984-1A8D92A4-600B-427E-A42E-5DB260CC91B2

Q28250984-22093159-BADB-4C73-843F-96C38315D66C

Q28250984-2741198D-E552-414C-BCFF-FD0954BB640A

Q28250984-280330BB-D9C6-49B5-AA99-B8104D9B5410

Q28250984-294C7A06-DC78-46EE-BA51-07CB35CA5C0C

Q28250984-2EAC9352-A38A-4744-A0BF-E0B703FA488A

P304

Q28250984-2B5B25DB-57D8-4B77-AACE-34581517820B

P31

Q28250984-90D8E0DD-2B35-4719-A486-65A635795955

Q28250984-A46BCE9C-8C0F-4783-8ACF-B874CB7C971D

P3181

Q28250984-474A3A82-B6A4-47BC-BD06-0F481FA82733

P356

Q28250984-C11FB232-DBF5-4241-804F-9DB6BE50DF2F

P407

Q28250984-803A3AC6-072C-4B76-B46F-A0873ED341D2

P433

Q28250984-6600191A-A315-4DE6-98B2-8447B80A009B

P478

Q28250984-EE3C98F3-B298-46C7-9B10-BF2B26D16615

P50

Q28250984-67D0F58C-5C54-432A-B6F3-FBD0C9E6A6AC

Q28250984-E4F4A8C4-C9F7-4CA0-8416-9A3059AF5EED

P577

Q28250984-83E1B4F8-3D82-4CA7-9314-2E8C03ECAF94

Q28250984-D12A6BDF-5B76-4DB9-805E-9DD16939F96A

P5875

Q28250984-74F733D6-3C31-4CB7-97DA-7D37DDB3F3C8

P698

Q28250984-7E194A64-349E-47EB-A4AC-90BE6C60EB7E

P921

Q28250984-1FE2ECBC-0D25-4D98-AA32-616B497C6801

Q28250984-250D0B06-00F5-4BA9-B152-DA1F50F469DE

Q28250984-36097DC8-9129-4F30-A604-FF62BF4FE454

Q28250984-5F29A4E8-200C-4C00-91E8-052FE356BD64

Q28250984-BDB30C58-5723-4B26-9648-CF2AD72B47A6

Q28250984-E30625C1-59A6-44E9-9F43-3BFBF559EA62

Q28250984-FECBD39E-547A-40FC-9CE0-9FABEE66F187

P932

Q28250984-B36F6365-A435-4D91-8186-474CDE3D6A3B

P3181

P356

P1433

P1476

Versican in inflammation and tissue remodeling: the impact on lung disorders

@en

P2093

Anders Malmström

http://www.w3.org/2001/XMLSchema#string

Anna-Karin Larsson-Callerfelt

http://www.w3.org/2001/XMLSchema#string

Annika Andersson-Sjöland

http://www.w3.org/2001/XMLSchema#string

Emil Tykesson

http://www.w3.org/2001/XMLSchema#string

Jenny C Karlsson

http://www.w3.org/2001/XMLSchema#string

Kristina Rydell-Törmänen

http://www.w3.org/2001/XMLSchema#string

Maria Weitoft

http://www.w3.org/2001/XMLSchema#string

Oskar Hallgren

http://www.w3.org/2001/XMLSchema#string

Sara Rolandsson

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial 4.0 License

P2860

Expression of versican 3'-untranslated region modulates endogenous microRNA functions

Multiple domains of the large fibroblast proteoglycan, versican

Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma

Differential expression profiling of membrane proteins by quantitative proteomics in a human mesenchymal stem cell line undergoing osteoblast differentiation

Repression of versican expression by microRNA-143

Transforming growth factor-beta1 in inflammatory airway disease: a key for understanding inflammation and remodeling

Iduronic acid in chondroitin/dermatan sulfate: biosynthesis and biological function

Structure, function and regulation of versican: the most abundant type of proteoglycan in the extracellular matrix

Iduronic acid in chondroitin/dermatan sulfate affects directional migration of aortic smooth muscle cells

The Wnt signaling pathway in development and disease

P304

243-51

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2139796

http://www.w3.org/2001/XMLSchema#string

P356

10.1093/GLYCOB/CWU120

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

Gunilla Westergren-Thorsson

P577

2015-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

267871297

http://www.w3.org/2001/XMLSchema#string

P698

25371494

http://www.w3.org/2001/XMLSchema#string

P921

Angliavandeniai

fibrous protein

P932

4310351

http://www.w3.org/2001/XMLSchema#string